CSS
ANIK icon

Cubist Systematic Strategies’s Anika Therapeutics ANIK Stock Holding History

Cubist Systematic Strategies’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$352K Buy
+37,447
New +$358K ﹤0.01% 2437
2025
Q1 		– Sell
-11,990
Closed -$197K – 2825
2024
Q4 		$197K Buy
11,990
+4,682
+64% +$92.3K ﹤0.01% 2575
2024
Q3 		$181K Sell
7,308
-3,970
-35% -$103K ﹤0.01% 2596
2024
Q2 		$286K Sell
11,278
-11,420
-50% -$296K ﹤0.01% 2376
2024
Q1 		$577K Sell
22,698
-16,820
-43% -$407K ﹤0.01% 2535
2023
Q4 		$895K Sell
39,518
-38,294
-49% -$792K 0.01% 2130
2023
Q3 		$1.45M Buy
+77,812
New +$1.61M 0.01% 1605
2022
Q4 		– Sell
-10,900
Closed -$259K – 4217
2022
Q3 		$259K Sell
10,900
-4,281
-28% -$98.5K ﹤0.01% 3602
2022
Q2 		$339K Buy
+15,181
New +$339K ﹤0.01% 3348
2022
Q1 		– Sell
-4,527
Closed -$162K – 3536
2021
Q4 		$162K Buy
+4,527
New +$181K ﹤0.01% 3093
2020
Q3 		– Sell
-7,783
Closed -$294K – 2475
2020
Q2 		$294K Sell
7,783
-13,152
-63% -$433K 0.01% 1854
2020
Q1 		$605K Sell
20,935
-169
-0.8% -$6.84K 0.02% 1134
2019
Q4 		$1.09M Buy
21,104
+12,425
+143% +$722K 0.02% 1103
2019
Q3 		$476K Sell
8,679
-4,891
-36% -$251K 0.01% 1310
2019
Q2 		$551K Buy
+13,570
New +$495K 0.01% 1415
2018
Q4 		– Sell
-6,267
Closed -$264K – 2038
2018
Q3 		$264K Buy
+6,267
New +$248K 0.01% 1256

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cubist Systematic Strategies's ANIK Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Anika Therapeutics (ANIK) in Q3 2025: 37,447 shares worth $352K. The stake represents ﹤0.01% of the portfolio and ranks #2437 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in ANIK as recently as Q4 2024.

Cubist Systematic Strategies first reported a position in ANIK in Q3 2018 and has held it in 16 quarters since. The position peaked at $1.45M in Q3 2023. 117 funds tracked by Wall St. Rank hold ANIK as of Q3 2025.

  • Cubist Systematic Strategies held 37,447 shares of Anika Therapeutics worth $352K as of Q3 2025.
  • Anika Therapeutics was a new Cubist Systematic Strategies position in Q3 2025.
  • Anika Therapeutics made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2437 holding.
  • Cubist Systematic Strategies first reported a position in Anika Therapeutics in Q3 2018 and has held it in 16 quarters since.
  • Cubist Systematic Strategies's Anika Therapeutics position peaked at $1.45M in Q3 2023.
  • 117 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.